Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by EMJ. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EMJ or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Hema Now: Episode 24: Understanding Myeloproliferative Neoplasms

32:58
 
Share
 

Manage episode 504158251 series 3412919
Content provided by EMJ. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EMJ or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, host Jonathan Sackier is joined by Andrew Dunbar, Assistant Professor in the Department of Hematopoietic Biology and Malignancy at the University of Texas MD Anderson Cancer Center, Houston, USA. Dunbar discusses his research into myeloproliferative neoplasms, what drives disease progression and resistance, and promising targets for treatment, while reflecting on the mission of his lab and what lies ahead for the field.

Timestamps

00:00 – Introduction

02:29 – One thing people should know about myeloproliferative neoplasms

05:01 – Dunbar’s background and research focus

08:00 – What would Dunbar do if not science and medicine?

10:24 – The basics of myeloproliferative neoplasms

14:30 – Myeloproliferative neoplasm diagnosis and treatment

16:49 – What drives disease progression and resistance?

18:30 – The mission of Dunbar’s lab

21:23 – Development of AJ1-11095

22:54 – Balancing the complexity of disease modelling with urgent clinical needs

24:03 – Promising targets and pathways

26:35 – What’s on the horizon?

28:40 – Three wishes

  continue reading

199 episodes

Artwork
iconShare
 
Manage episode 504158251 series 3412919
Content provided by EMJ. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EMJ or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, host Jonathan Sackier is joined by Andrew Dunbar, Assistant Professor in the Department of Hematopoietic Biology and Malignancy at the University of Texas MD Anderson Cancer Center, Houston, USA. Dunbar discusses his research into myeloproliferative neoplasms, what drives disease progression and resistance, and promising targets for treatment, while reflecting on the mission of his lab and what lies ahead for the field.

Timestamps

00:00 – Introduction

02:29 – One thing people should know about myeloproliferative neoplasms

05:01 – Dunbar’s background and research focus

08:00 – What would Dunbar do if not science and medicine?

10:24 – The basics of myeloproliferative neoplasms

14:30 – Myeloproliferative neoplasm diagnosis and treatment

16:49 – What drives disease progression and resistance?

18:30 – The mission of Dunbar’s lab

21:23 – Development of AJ1-11095

22:54 – Balancing the complexity of disease modelling with urgent clinical needs

24:03 – Promising targets and pathways

26:35 – What’s on the horizon?

28:40 – Three wishes

  continue reading

199 episodes

Alle episoder

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play